Hereditary hemorrhagic telangiectasia
2 papers3 findings
- Humans1
- Cells1
Effects
1Lifespan
downin humans1
1 study
Lifespan
downin humans1
Hereditary hemorrhagic telangiectasia shortens lifespan in humans (73.0 (68.0-77.2) vs 80.5 (79.1-82.0) years).
“Life expectancy for cases with HHT after age 30 was estimated at 73.0 (68.0-77.2) compared to 80.5 (79.1-82.0) years for controls.”
Humansafter age 30, matched controls comparatorfollow-up until 2018
Journal of internal medicineJul 6, 2026
Associations
2Liver disease
upin humans1
1 study
Liver disease
upin humans1
Hereditary hemorrhagic telangiectasia raises the risk of liver disease in humans.
“Ischemic heart diseases, diseases of arteries, arterioles, capillaries, and liver diseases were significantly more common causes of death among HHT patients.”
Humanscause of death
Journal of internal medicineJul 6, 2026
Ischemic heart disease
upin humans1
1 study
Ischemic heart disease
upin humans1
Hereditary hemorrhagic telangiectasia raises the risk of ischemic heart disease in humans.
“Ischemic heart diseases, diseases of arteries, arterioles, capillaries, and liver diseases were significantly more common causes of death among HHT patients.”
Humanscause of death
Journal of internal medicineJul 6, 2026
Trial sponsors
3 trialsPhase 233 people
1 trialPhase 2123 people
1 trialPhase 260 people
1 trialPhase 127 people
Latest
1 in 12 monthsJournal of Internal Medicine
Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population-based registry study
Cohort study of 1,965 peoplePopulations
Cell & Bioscience
Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT)
Experiments in human cellsMechanisms